Search results
Bristol Myers Gets CHMP Backing for Opdivo Combo in Bladder Cancer
Morningstar· 7 days agoSquibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its blockbuster cancer drug& ...
Vor Bio appoints new board member with oncology expertise By Investing.com
Investing.com· 7 hours agoDr. Namouni brings over two decades of experience in oncology and cancer immunotherapy drug...
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Reuters via Yahoo Finance· 3 days agoOno Pharma is best known globally for its blockbuster cancer drug Opdivo, which is sold in the U.S. by partner Bristol-Myers Squibb.
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 21 hours agoCancer drugs are highly prized in the industry for their pricing power, favorable reimbursement status...Strong performance of key drugs: Vyndaqel: This...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 7 days agoThe company will be running three trials with EXL01, but the...in the treatment arm will receive...
Yervoy cost 2024: Coupons and more
Medical News Today· 2 days agoYervoy (ipilimumab) is a brand-name solution for intravenous injection. It’s prescribed for certain types of cancer, including melanoma, kidney cancer,...
Greenberg Traurig, Goodwin Act on Japanese Pharma’s $2.4B American Acquisition | Law.com...
Law.com· 12 hours agoGreenberg Traurig advised ONO Pharmaceuticals while Goodwin Procter acted for Deciphera.
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 4 days agoThe drug’s PTSR decreased by 11 points to 34% in bile duct cancer, 10 points to 35% in gallbladder ...
Japan's Ono Pharma to buy U.S. drugmaker Deciphera for $2.4bn
Nikkei Asian Review· 2 days agoCompany seeks new revenue as patent expirations loom on cash-cow product
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 7 days agoTotal sales of the immuno-oncology drug Opdivo, approved for multiple cancer indications, went down...
